Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | AXL |
| Variant | negative |
| Impact List | unknown |
| Protein Effect | loss of function |
| Gene Variant Descriptions | AXL negative indicates a lack of expression of the AXL mRNA and/or protein. |
| Associated Drug Resistance | |
| Category Variants Paths |
AXL mutant AXL inact mut AXL negative |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| AXL negative | head and neck squamous cell carcinoma | decreased response | Bemcentinib | Preclinical | Actionable | In a preclinical study, Bemcentinib (BGB-324) did not inhibit proliferation or invasion of AXL-negative head and neck squamous cell carcinoma cell lines in culture (PMID: 25767293). | 25767293 |